Hereditary cancer
Identify how your patient’s genetics may facilitate preventative interventions and early detection, as well as recognize at-risk family members.
sequence once, query often®
TURNAROUND
Existing Patient (SOQO)Ⓡ< 5 days
TURNAROUND
New Patient6-21 days
SAMPLE
Saliva, Blood, Buccal
One comprehensive test provides clinical answers today and enables future queries as science evolves.
If your patient has been sequenced before, Helix will automatically flag them as an existing patient in your EHR ordering workflow. No new sample required.
Clinical Utility
Identifies individuals with a hereditary predisposition to cancer who may benefit from:
- Increased cancer screening
- Risk-reducing surgeries
- Chemoprevention
- Targeted therapies (e.g., PARP inhibitors)
- Clarification of risk for family members
TECH SPECS
Methodology
Exome+® NGS (exome capture + deep intronic coverage in key regions + relevant promoters and inversions).
Accuracy
> 99.9% analytical sensitivity for SNVs and small indels.
CNV resolution
Single exon-level resolution for deletions and duplications.
Wayfinder™ interpretation
Automated pathogenicity scoring powered by 3M+ longitudinal records and AI synthesis for superior intelligence.
Test Catalog
Select a test below to view a detailed test description, technical specifications and complete gene list.
Hereditary Multi-Cancer Panel
A comprehensive 70-gene panel for assessing hereditary risk across breast, gynecologic, colorectal, ...
70
genesHereditary Breast and Gynecologic Cancers Panel
A 21-gene panel for assessing hereditary risk for breast, ovarian, and uterine cancers, powered by t...
21
genesHereditary Breast Cancer Panel
A focused 13-gene panel for evaluating hereditary breast cancer predisposition, powered by the Helix...
13
genesHereditary Colorectal Cancer Panel
A 19-gene panel for evaluating hereditary predisposition to colon polyps and colorectal cancer, powe...
19
genes